Luc Mercken

1.6k total citations
39 papers, 1.3k citations indexed

About

Luc Mercken is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Luc Mercken has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Physiology and 9 papers in Cell Biology. Recurrent topics in Luc Mercken's work include Alzheimer's disease research and treatments (16 papers), Prion Diseases and Protein Misfolding (4 papers) and Calpain Protease Function and Regulation (4 papers). Luc Mercken is often cited by papers focused on Alzheimer's disease research and treatments (16 papers), Prion Diseases and Protein Misfolding (4 papers) and Calpain Protease Function and Regulation (4 papers). Luc Mercken collaborates with scholars based in France, Belgium and Netherlands. Luc Mercken's co-authors include Gilbert Vassart, Stéphane Swillens, Marc Massaer, Laurent Pradier, Jean‐Philippe Loeffler, Jasmine Parma, Q. Dong, Martijn Simons, Michael Ricketts and Viviane Pohl and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Luc Mercken

39 papers receiving 1.3k citations

Peers

Luc Mercken
Kristina S. Kovacina United States
Shawn Jeffries United States
Lina Udd Finland
Bryan R. Reep United States
Kristina S. Kovacina United States
Luc Mercken
Citations per year, relative to Luc Mercken Luc Mercken (= 1×) peers Kristina S. Kovacina

Countries citing papers authored by Luc Mercken

Since Specialization
Citations

This map shows the geographic impact of Luc Mercken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Mercken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Mercken more than expected).

Fields of papers citing papers by Luc Mercken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luc Mercken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Mercken. The network helps show where Luc Mercken may publish in the future.

Co-authorship network of co-authors of Luc Mercken

This figure shows the co-authorship network connecting the top 25 collaborators of Luc Mercken. A scholar is included among the top collaborators of Luc Mercken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luc Mercken. Luc Mercken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santiard-Baron, Dominique, Dominique Langui, Maryse Delehedde, et al.. (2005). Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in β‐amyloid load. Journal of Neurochemistry. 93(2). 330–338. 45 indexed citations
2.
Aguilar, José‐Luis González de, Violaine Sée, Luc Dupuis, et al.. (2005). Antibody-bound β-amyloid precursor protein stimulates the production of tumor necrosis factor-α and monocyte chemoattractant protein-1 by cortical neurons. Neurobiology of Disease. 19(1-2). 129–141. 12 indexed citations
3.
Robert, Sylvain J., et al.. (2005). Regulation of the amyloid precursor protein ectodomain shedding by the 5‐HT4 receptor and Epac. FEBS Letters. 579(5). 1136–1142. 44 indexed citations
4.
Fischer, David F., Jacqueline A. Sluijs, M.A.F. Sonnemans, et al.. (2004). Frame‐shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid β40. Journal of Neurochemistry. 90(3). 712–723. 10 indexed citations
5.
Cousin, Emmanuelle, Didier Hannequin, Sylvain Ricard, et al.. (2003). A risk for early-onset Alzheimer's disease associated with the APBB1 gene (FE65) intron 13 polymorphism. Neuroscience Letters. 342(1-2). 5–8. 12 indexed citations
6.
Gianni, Davide, Nicola Zambrano, Marida Bimonte, et al.. (2003). Platelet-derived Growth Factor Induces the β-γ-Secretase-mediated Cleavage of Alzheimer's Amyloid Precursor Protein through a Src-Rac-dependent Pathway. Journal of Biological Chemistry. 278(11). 9290–9297. 67 indexed citations
7.
8.
Delatour, Benoı̂t, Luc Mercken, Khalid Hamid El Hachimi, et al.. (2001). FE65 in Alzheimer’s Disease. American Journal Of Pathology. 158(5). 1585–1591. 30 indexed citations
9.
Octave, Jean‐Noël, Rachid Essalmani, Bernadette Tasiaux, et al.. (2000). The Role of Presenilin-1 in the γ-Secretase Cleavage of the Amyloid Precursor Protein of Alzheimer's Disease. Journal of Biological Chemistry. 275(3). 1525–1528. 35 indexed citations
10.
Dupuis, Luc, Marc de Tapia, Frédérique René, et al.. (2000). Differential Screening of Mutated SOD1 Transgenic Mice Reveals Early Up-Regulation of a Fast Axonal Transport Component in Spinal Cord Motor Neurons. Neurobiology of Disease. 7(4). 274–285. 50 indexed citations
11.
Pradier, Laurent, Nathalie Carpentier, Luc Buée, et al.. (1999). Mapping the APP/Presenilin (PS) Binding Domains: The Hydrophilic N-Terminus of PS2 Is Sufficient for Interaction with APP and Can Displace APP/PS1 Interaction. Neurobiology of Disease. 6(1). 43–55. 30 indexed citations
12.
Essalmani, Rachid, Jean-Marc Guillaume, Luc Mercken, & J.N. Octave. (1996). Baculovirus‐infected cells do not produce the amyloid peptide of Alzheimer's disease from its precursor. FEBS Letters. 389(2). 157–161. 6 indexed citations
13.
Mercken, Luc, Françoise Apiou, Laurent Pradier, et al.. (1996). Molecular Cloning, Functional Expression, Pharmacological Characterization and Chromosomal Localization of the Human Metabotropic Glutamate Receptor Type 3. Neuropharmacology. 35(5). 523–530. 17 indexed citations
14.
Essalmani, Rachid, et al.. (1996). Missense Mutations Associated with Familial Alzheimer's Disease in Sweden Lead to the Production of the Amyloid Peptide without Internalization of Its Precursor. Biochemical and Biophysical Research Communications. 218(1). 89–96. 19 indexed citations
15.
Mercken, Luc & Jean‐Pierre Brion. (1995). Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E. Neuroreport. 6(17). 2381–2384. 20 indexed citations
16.
Mercken, Luc, et al.. (1991). An exon 5-deleted mrna encodes a functional interleukin 2 receptor alpha-subunit. Biochemical and Biophysical Research Communications. 180(3). 1390–1395. 1 indexed citations
17.
Ommen, Gert‐Jan B. van, et al.. (1989). Studies on the structures of the normal and abnormal goat thyroglobulin genes. Biochimie. 71(2). 211–221. 17 indexed citations
18.
Mercken, Luc, et al.. (1989). Alternative splicing may be responsible for heterogeneity of thyroglobulin structure. Biochimie. 71(2). 223–226. 23 indexed citations
19.
Mercken, Luc, et al.. (1985). Presence of hormonogenic and repetitive domains in the first 930 amino acids of bovine thyroglobulin as deduced from the cDNA sequence. European Journal of Biochemistry. 147(1). 59–64. 19 indexed citations
20.
Mercken, Luc, et al.. (1983). Partial sequencing of bovine thyroglobulin mRNA. Annales d Endocrinologie. 44. 105. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026